Accretive Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.54M Buy
18,571
+2,018
+12% +$470K 1.28% 16
2025
Q4
$3.43M Buy
16,553
+575
+4% +$114K 1.02% 23
2025
Q3
$2.96M Buy
15,978
+119
+0.8% +$20.4K 0.9% 33
2025
Q2
$2.42M Buy
15,859
+171
+1% +$26.3K 0.79% 39
2025
Q1
$2.42M Buy
15,688
+4,424
+39% +$692K 0.86% 36
2024
Q4
$1.63M Sell
11,264
-8
-0.1% -$1.24K 0.69% 50
2024
Q3
$1.83M Sell
11,272
-1,229
-10% -$196K 0.76% 43
2024
Q2
$1.83M Buy
12,501
+680
+6% +$101K 0.76% 38
2024
Q1
$1.76M Buy
11,821
+164
+1% +$26.1K 0.78% 39
2023
Q4
$1.83M Sell
11,657
-16
-0.1% -$2.45K 0.88% 33
2023
Q3
$1.82M Sell
11,673
-165
-1% -$27.2K 1.08% 22
2023
Q2
$1.96M Sell
11,838
-187
-2% -$30.2K 1.16% 19
2023
Q1
$1.86M Buy
12,025
+133
+1% +$21.5K 1.19% 17
2022
Q4
$2.1M Buy
11,892
+767
+7% +$132K 1.44% 15
2022
Q3
$1.82M Buy
11,125
+3
+0% +$508 1.38% 17
2022
Q2
$1.97M Buy
11,122
+31
+0.3% +$5.52K 1.43% 16
2022
Q1
$1.97M Buy
11,091
+176
+2% +$29.9K 1.23% 18
2021
Q4
$1.87M Buy
10,915
+366
+3% +$59.9K 1.19% 19
2021
Q3
$1.7M Buy
10,549
+627
+6% +$107K 1.2% 17
2021
Q2
$1.64M Buy
9,922
+3,279
+49% +$543K 1.18% 17
2021
Q1
$1.09M Buy
6,643
+325
+5% +$52.6K 0.98% 31
2020
Q4
$994K Buy
+6,318
New +$932K 0.98% 30

Other funds holding JNJ

Accretive Wealth Partners's JNJ Position: Q1 2026 in Review

Accretive Wealth Partners increased its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, buying an estimated $470K and bringing the position to 18,571 shares worth $4.54M. The position accounts for 1.28% of the portfolio, ranked #16.

Accretive Wealth Partners first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Accretive Wealth Partners held 18,571 shares of Johnson & Johnson worth $4.54M as of Q1 2026.
  • Accretive Wealth Partners bought 2,018 Johnson & Johnson shares in Q1 2026, an estimated $470K.
  • Johnson & Johnson made up 1.28% of Accretive Wealth Partners's portfolio in Q1 2026, its #16 holding.
  • Accretive Wealth Partners first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Accretive Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.